Robuta

https://www.acc.org/About-ACC/Press-Releases/2025/03/29/15/34/Rivaroxaban-Comparable-to-Warfarin
left ventricularblood clotsrivaroxabancomparablewarfarin
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=e62f23c6-89f2-4179-95dc-5732401b3f93&type=display
do notthe informationhighlightsincludeneeded
https://cardiologia.xagena.net/farmaci/1fa19a98316222ab4bcac1af0412e2ab.html
Il nuovo anticoagulante orale Rivaroxaban in compresse da 20 mg assunto una volta al giorno ha ridotto in misura significativa, ...
rivaroxabanproducenelladelvenoso
https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2011/08/10/17/50/Rivaroxaban-Versus-Warfarin-in-Nonvalvular-Atrial-Fibrillation
atrial fibrillationamerican collegerivaroxabanversuswarfarin
https://www.scirp.org/journal/PaperInformation?PaperID=53946&
Study compares Rivaroxaban and Dalteparin sodium as prophylactic antithrombotic medications after total knee arthroplasty. Findings show no significant...
deep vein thrombosiscomparisonclinicalresultstotal
https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2020/06/23/14/12/Post-Discharge-Prophylaxis-With-Rivaroxaban
Geoffrey D. Barnes, MD, MSc, FACC
thromboembolic eventsamerican collegerivaroxabanreducesmedically
https://pubmed.ncbi.nlm.nih.gov/28835439/
There is uncertainty regarding the effectiveness and occurrence of thromboembolic events in patients treated with prothrombin complex concentrates (PCCs) for...
major bleedingmanagementrivaroxabanapixabanassociated
https://pubmed.ncbi.nlm.nih.gov/34780886/
Edoxaban was associated with better effectiveness compared with other OACs in AF patients from Germany. Edoxaban also demonstrated a favorable safety profile.
comparisonclinicaloutcomesedoxabanversus